Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers

Dr. Glenn M. Chertow, MD

(Dr. Glenn Matthew Chertow, MD)

(No ratings)

Specializes in: Adult Nephrology

Harvard Medical School (1989)

Professional interests include: kidney failure, dialysis, kidney problems, and more.

774 11th Avenue
San Francisco, CA 94118

(415) 221-1093

Dr. Glenn M. Chertow, MD is a nephrologist in Pinole, CA specializing in adult nephrology. He graduated from Harvard Medical School in 1989 and has 37 years of experience. Dr. Glenn M. Chertow, MD is affiliated with Stanford Medicine Children's Health and Stanford Health Care.

Office Locations

Stanford Health Care

2160 Appian Way Suite 200, Kidney Clinic In Pinole
Pinole, CA 94564

(510) 237-2802

open_in_new

Stanford Health Care

300 Pasteur Drive Floor 1 Suite A11
Palo Alto, CA 94305

(650) 723-6961

open_in_new

774 11th Avenue
San Francisco, CA 94118

(415) 221-1093

open_in_new

Stanford Medicine Children's Health

777 Welch Road Suite De
Palo Alto, CA 94304

(650) 723-6961

open_in_new

900 Blake Wilbur Drive Floor 2
Palo Alto, CA 94304

open_in_new

Some issues Dr. Glenn M. Chertow, MD can help you with:

Dialysis

Dialysis is a procedure that replicates renal (kidney) function by filtering patients' blood. When kidneys do not work properly, waste can accumulate in the blood and unbalanced chemicals can impair the body's critical functions. In order to stay healthy, a person without proper kidney function must receive dialysis. There are two forms of dialysis treatment: hemodialysis and peritoneal dialysis. Both forms of dialysis are recurring treatments that in many cases last throughout the lifetime of the affected patient. Patients who briefly lose renal function may slowly reduce the frequency of dialysis sessions until their kidneys recover. However, most patients who start on dialysis remain on dialysis for the rest of their lives or until they receive a kidney transplant.

A number of conditions can worsen renal function and lead to end-stage or acute kidney failure. When kidneys fail (i.e. nearly 90 percent of their function is lost), dialysis is typically prescribed. Conditions that cause chronic kidney failure (eventually requiring dialysis) include:

Type 1 and 2 Diabetes
Pyelonephritis, recurring kidney infection
Glomerulonephritis, inflammation of the kidney's filtering parts
Polycystic kidney disease
Interstitial nephritis, inflammation of the kidney's tubules
High blood pressure
Vesicoureteral reflux, improper bladder emptying

For hemodialysis (the more common form of dialysis), a patient will visit a hospital or clinic and be connected to a dialysis machine by a needle attached to a tube that draws blood from the arm. The drawn blood is transferred to the dialysis machine, where it is filtered and separated until clean. Waste products from the blood pass into a fluid called dialysate, which is pumped out of the machine into a waste receptacle. The machine also measures and helps ensure the blood has the appropriate level of fluid, electrolytes, and pH. A tube delivers the cleaned blood back into the patient's body. A dialysis session like this will typically last for three to four hours, with a patient undergoing dialysis around three times per week.

A second method of dialysis is known as peritoneal dialysis. Unlike hemodialysis, peritoneal dialysis can be performed at home by oneself after an initial surgery. To start, a physician (generally a surgeon) will make a small incision in the lower abdomen and insert and surgically attach a catheter (thin tube). At home, the patient connects a pump to the abdomen catheter, delivering dialysate (dialysis fluid) from a bag hanging on a wheeled stand. This fluid enters the peritoneal cavity (greater abdomen area containing the stomach, liver, and intestines) and collects waste through osmosis, where waste in the blood moves across a membrane and into the dialysate. This process continues for several hours until the fluid concentration is equal between the blood and dialysate, at which point the fluid can be drained. The fluid can then be passed through a machine called a cycler, which removes waste and allows for the dialysate to be reused. This process is repeated about four times per day. Dialysis patients must limit the amount of fluid they consume prior to receiving dialysis and should also avoid eating salty foods. The cycler cannot filter more than a certain amount of waste products from the blood.

Kidneys are important organs, and dialysis treatments are vital for those with renal dysfunction. For many, dialysis is not so much a medical procedure but a part of their normal life.

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

In The News (see more mentions in the news)

“"Patients receiving maintenance dialysis would benefit from additional therapeutic options that can effectively increase and maintain hemoglobin concentrations within guideline-recommended target...”—"Vafseo(r) approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients", WIVB, March 2024

“"Patients receiving maintenance dialysis would benefit from additional therapeutic options that can effectively increase and maintain hemoglobin concentrations within guideline-recommended target...”—"Once-Rejected Drug Now FDA Approved for CKD-Related Anemia", MedPage Today, March 2024

“"Hyperphosphatemia management has been a persistent clinical challenge, as the majority of patients receiving maintenance dialysis are unable to consistently achieve target serum phosphate...”—"FDA Approves First Phosphate Absorption Inhibitor for CKD", MedPage Today, October 2023

Noteworthy Medicare Patient Procedures Performed by Dr. Glenn M. Chertow, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

hemofiltration

In 2023, Dr. Glenn M. Chertow, MD performed more hemofiltration procedures for Medicare patients than 95% of providers in related specialties within California.

Top 25%

By Volume:

dialysis

In 2012, Dr. Glenn M. Chertow, MD performed more dialysis procedures for Medicare patients than 75% of providers in related specialties within California.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2012 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	183
doctor visit	115
hemofiltration	49
hospital care	293
inpatient care	293

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2013 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	169
doctor visit	143
hemofiltration	51
hospital care	345
inpatient care	345

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	156
Female	123

**Ethnicity**
Non-Hispanic White	121
Black	28
Hispanic	58
Asian	61
Other	0
Native American	0

**Age**
From 65 to 74	81
From 75 to 84	66
85 and over	25
Less than 65	107

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2013

Hypertension	75
High Cholesterol	70
Stroke	9
Ischemic Heart Disease	50
Depression	29
Chronic Kidney Disease	75
Asthma	12
Osteoperosis	9
Atrial Fibrilation	18
Heart Failure	51
Chronic Obstructive Pulmonary Disease	15
Diabetes	54
Dementia	14
Cancer	12

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2014 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	205
doctor visit	143
hemofiltration	61
hospital care	318
inpatient care	318

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	156
Female	125

**Ethnicity**
Non-Hispanic White	132
Black	31
Hispanic	54
Asian	53
Other	0
Native American	0

**Age**
From 65 to 74	83
From 75 to 84	50
85 and over	26
Less than 65	122

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2014

Hypertension	75
High Cholesterol	64
Stroke	9
Ischemic Heart Disease	51
Depression	28
Chronic Kidney Disease	75
Asthma	16
Osteoperosis	8
Atrial Fibrilation	24
Heart Failure	52
Chronic Obstructive Pulmonary Disease	22
Diabetes	51
Dementia	13
Cancer	11

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2015 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	207
doctor visit	96
hemofiltration	95
hospital care	253
inpatient care	253

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	264
Female	196

**Ethnicity**
Non-Hispanic White	208
Black	58
Hispanic	84
Asian	80
Other	0
Native American	0

**Age**
From 65 to 74	140
From 75 to 84	108
85 and over	40
Less than 65	172

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2015

Hypertension	75
High Cholesterol	67
Stroke	13
Ischemic Heart Disease	58
Depression	29
Chronic Kidney Disease	75
Asthma	11
Osteoperosis	8
Atrial Fibrilation	24
Heart Failure	53
Chronic Obstructive Pulmonary Disease	15
Diabetes	56
Dementia	15
Cancer	11

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2016 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	166
doctor visit	126
hemofiltration	59
hospital care	170
inpatient care	170

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	125
Female	115

**Ethnicity**
Non-Hispanic White	105
Black	24
Hispanic	54
Asian	43
Other	0
Native American	0

**Age**
From 65 to 74	77
From 75 to 84	62
85 and over	26
Less than 65	75

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2016

Hypertension	75
High Cholesterol	70
Stroke	13
Ischemic Heart Disease	58
Depression	24
Chronic Kidney Disease	75
Asthma	21
Osteoperosis	10
Atrial Fibrilation	24
Heart Failure	56
Chronic Obstructive Pulmonary Disease	18
Diabetes	62
Dementia	22
Cancer	13

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2017 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	133
doctor visit	131
hemofiltration	44
hospital care	200
inpatient care	200

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	126
Female	103

**Ethnicity**
Non-Hispanic White	99
Black	29
Hispanic	47
Asian	38
Other	0
Native American	0

**Age**
From 65 to 74	84
From 75 to 84	43
85 and over	24
Less than 65	78

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2017

Hypertension	75
High Cholesterol	62
Stroke	10
Ischemic Heart Disease	51
Depression	29
Chronic Kidney Disease	75
Asthma	11
Osteoperosis	6
Atrial Fibrilation	18
Heart Failure	52
Chronic Obstructive Pulmonary Disease	14
Diabetes	57
Dementia	21
Cancer	10

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2018 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	180
doctor visit	140
hemofiltration	65
hospital care	201
inpatient care	201

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	142
Female	101

**Ethnicity**
Non-Hispanic White	108
Black	28
Hispanic	45
Asian	47
Other	0
Native American	0

**Age**
From 65 to 74	82
From 75 to 84	56
85 and over	26
Less than 65	79

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2018

Hypertension	75
High Cholesterol	66
Stroke	11
Ischemic Heart Disease	53
Depression	28
Chronic Kidney Disease	75
Asthma	11
Osteoperosis	7
Atrial Fibrilation	20
Heart Failure	51
Chronic Obstructive Pulmonary Disease	15
Diabetes	60
Dementia	27
Cancer	9

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2019 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	116
doctor visit	135
hemofiltration	47
hospital care	134
inpatient care	134

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	130
Female	96

**Ethnicity**
Non-Hispanic White	99
Black	31
Hispanic	39
Asian	40
Other	17
Native American	0

**Age**
From 65 to 74	79
From 75 to 84	57
85 and over	27
Less than 65	63

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2019

Hypertension	75
High Cholesterol	68
Stroke	8
Ischemic Heart Disease	56
Depression	29
Chronic Kidney Disease	75
Asthma	8
Osteoperosis	14
Atrial Fibrilation	19
Heart Failure	50
Chronic Obstructive Pulmonary Disease	16
Diabetes	58
Dementia	23
Cancer	14

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2020 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	239
doctor visit	75
hemofiltration	138
hospital care	323
inpatient care	323

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	154
Female	120

**Ethnicity**
Non-Hispanic White	116
Black	40
Hispanic	51
Asian	48
Other	19
Native American	0

**Age**
From 65 to 74	76
From 75 to 84	69
85 and over	30
Less than 65	99

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2020

Hypertension	75
High Cholesterol	69
Stroke	15
Ischemic Heart Disease	61
Depression	26
Chronic Kidney Disease	75
Asthma	11
Osteoperosis	13
Atrial Fibrilation	27
Heart Failure	59
Chronic Obstructive Pulmonary Disease	14
Diabetes	59
Dementia	28
Cancer	13

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2021 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	235
doctor visit	118
hemofiltration	126
hospital care	265
inpatient care	265

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	156
Female	132

**Ethnicity**
Non-Hispanic White	132
Black	29
Hispanic	50
Asian	57
Other	0
Native American	0

**Age**
From 65 to 74	106
From 75 to 84	85
85 and over	34
Less than 65	63

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2021

Hypertension	75
High Cholesterol	69
Stroke	14
Ischemic Heart Disease	59
Depression	28
Chronic Kidney Disease	75
Asthma	11
Osteoperosis	16
Atrial Fibrilation	28
Heart Failure	55
Chronic Obstructive Pulmonary Disease	15
Diabetes	54
Dementia	31
Cancer	17

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA during 2022 were hospital care, inpatient care, dialysis and hemofiltration.

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

dialysis	184
doctor visit	142
hemofiltration	65
hospital care	281
inpatient care	281

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	159
Female	123

**Ethnicity**
Non-Hispanic White	131
Black	33
Hispanic	39
Asian	63
Other	16
Native American	0

**Age**
From 65 to 74	92
From 75 to 84	86
85 and over	43
Less than 65	61

Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD in 2022

Hypertension	75
High Cholesterol	75
Stroke	22
Ischemic Heart Disease	51
Depression	27
Chronic Kidney Disease	75
Asthma	15
Osteoperosis	18
Atrial Fibrilation	39
Heart Failure	54
Chronic Obstructive Pulmonary Disease	26
Diabetes	64
Dementia	21
Cancer	20

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Glenn M. Chertow, MD for Medicare patients.

The highest averages for the top procedures that Dr. Glenn M. Chertow, MD treated as a nephrologist in Pinole, CA were hospital care, inpatient care, dialysis and hemofiltration.

dialysis	183
doctor visit	124
hemofiltration	72
hospital care	253
inpatient care	253

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Glenn M. Chertow, MD.

**Gender**
Male	142
Female	112

**Ethnicity**
Black / African American	30
Asian / Pacific Islander	48
Non-Hispanic White	113
Native American / Alaskan Native	0
Hispanic	47
Other	4

**Age**
75 to 84	62
85 and over	27
Less than 65	83
65 to 74	81

Average of Total of Conditions of Medicare patients treated by Dr. Glenn M. Chertow, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Glenn M. Chertow, MD treated were chronic kidney disease, hypertension, high cholesterol and diabetes.

Hypertension	68
High Cholesterol	61
Stroke	11
Ischemic Heart Disease	49
Depression	25
Chronic Kidney Disease	68
Asthma	11
Osteoporosis	9
Heart Failure	48
Chronic Obstructive Pulmonary Disease	15
Diabetes	52
Atrial Fibrillation	21
Dementia	19
Cancer	11

Education & Training

Dr. Glenn M. Chertow, MD graduated from Harvard Medical School in 1989. He completed residency at Brigham and Women's Hospital. He is certified by the American Board of Internal Medicine, Internal Medicine American Board of Internal Medicine, Nephrology and has a state license in California.

Medical School: Harvard Medical School (1989)

Residency: Brigham and Women's Hospital (1992)

Board Certification: American Board of Internal Medicine, Internal Medicine American Board of Internal Medicine, Nephrology

Licensed In: California

Affiliations & Hospitals

Dr. Glenn M. Chertow, MD is associated with these hospitals and organizations:

Stanford Medicine Children's Health

Stanford Health Care

Ratings & Reviews

Dr. Glenn M. Chertow, MD does not have any reviews yet, be the first to leave a review of Dr. Glenn M. Chertow, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Glenn M. Chertow, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Outset Medical Inc	$595,866 $595,866
AKEBIA THERAPEUTICS INC	$215,667 Auryxia $62,019	$153,648
Ardelyx, Inc.	$168,500 XPHOZAH 30 MG $47,900	$120,600
Amgen Inc.	$138,633 EPOGEN $47,786	Parsabiv $7,874	Tavneos $778	$82,195
AstraZeneca Pharmaceuticals LP	$114,888 LOKELMA $7,500	FARXIGA $4,318	$103,070
Other	$486,242 Non-Covered $51,344	FARXIGA $31,316	Auryxia $31,194	Feraheme $19,856	Renal - Theranova $16,919	Other $335,614

**Types of Payments**
Consulting Fee	$1,521,109
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$159,902
Travel and Lodging	$31,454
Food and Beverage	$5,883
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program	$1,050
Other	$399

Research Payments

Dr. Glenn M. Chertow, MD has received 35 research payments totaling $801,575.

Ownership and Interest Payments

This table describes ownership payments received by Dr. Glenn M. Chertow, MD.

Outset Medical Inc

2017

$675.00

Physician Covered Recipient

Gain on exercise of non-qualified stock options

Biography

Dr. Glenn Chertow is a physician who specializes in adult nephrology. These areas are among his clinical interests: polycystic kidney disease, kidney stones, and glomerulonephritis. His professional affiliations include Stanford Medicine Children's Health and Stanford Health Care. After attending Harvard Medical School, Dr. Chertow completed his residency training at Brigham and Women's Hospital. Awards and/or distinctions he has received include "Best Doctors in America" designation, Woodward and White; "Best Doctors in Boston" designation; and Boston Magazine. He is conversant in Spanish.